{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:09:53Z","timestamp":1783555793082,"version":"3.55.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,10,1]]},"abstract":"<jats:p>The cyclin-dependent kinase inhibitorp57KIP2 is thought to be a potential tumor suppressor gene (TSG). The present study examines this possibility. We found that the expression ofp57KIP2 gene is absent in various hematological cell lines. Exposing cell lines to the DNA demethylating agent 5-aza-2\u2032-deoxycytidine restoredp57KIP2 gene expression. Bisulfite sequencing analysis of its promoter region showed thatp57KIP2 DNA was completely methylated in cell lines that did not express thep57KIP2 gene. Thus, DNA methylation of its promoter might lead to inactivation of thep57KIP2 gene. DNA methylation of this region is thought to be an aberrant alteration, since DNA was not methylated in normal peripheral blood mononuclear cells or in reactive lymphadenitis. Methylation-specific polymerase chain reaction analysis found frequent DNA methylation of thep57KIP2 gene in primary diffuse large B-cell lymphoma (54.9%) and in follicular lymphoma (44.0%), but methylation was infrequent in myelodysplastic syndrome and adult T-cell leukemia (3.0% and 2.0%, respectively). These findings directly indicate that the profile of the p57KIP2gene corresponds to that of a TSG.<\/jats:p>","DOI":"10.1182\/blood-2001-11-0026","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T12:26:06Z","timestamp":1032351966000},"page":"2572-2577","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":106,"title":["Aberrant DNA methylation ofp57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype"],"prefix":"10.1182","volume":"100","author":[{"given":"Yinghua","family":"Li","sequence":"first","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihito","family":"Ohno","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yuge","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Hatano","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Mori","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"From the First Department of Internal Medicine, and the First Department of Pathology, Nagoya University School of Medicine; the Department of Hematology, Nagoya National Hospital; and the Aichi Blood Disease Research Foundation, Nagoya, Japan; and from the Department of Pediatrics, School of Medicine, Hirosaki University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111900180897300_B1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: cycling on cue.","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell."},{"key":"2019111900180897300_B2","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood.V83.12.3689.3689","article-title":"Rearrangement of CCND1 (BCL1\/PRAD1) 3\u2032 untranslated region in mantle cell lymphomas and t(11q13) associated leukemias.","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood."},{"key":"2019111900180897300_B3","first-page":"567","article-title":"Cyclin D1 protein expression in mantle cell lymphoma.","volume":"6","author":"Zukerberg","year":"1994","journal-title":"Ann Oncol."},{"key":"2019111900180897300_B4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.1998.16.3.1197","article-title":"Role of p16 tumor suppressor gene in cancer.","volume":"16","author":"Liggett","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019111900180897300_B5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell cycle control causing specific inhibition of cyclin D\/CDK4.","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature."},{"key":"2019111900180897300_B6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effecter of TGF-\u03b2-induced cell cycle arrest.","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature."},{"key":"2019111900180897300_B7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, potential mediator of p53 tumor suppression.","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell."},{"key":"2019111900180897300_B8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/366707a0","article-title":"Inhibition of CDK2 activity in vivo by associated 20K regulatory subunit.","volume":"366","author":"Gu","year":"1993","journal-title":"Nature."},{"key":"2019111900180897300_B9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell."},{"key":"2019111900180897300_B10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.9.6.639","article-title":"Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.","volume":"9","author":"Lee","year":"1995","journal-title":"Genes Dev."},{"key":"2019111900180897300_B11","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1182\/blood.V84.11.3781.bloodjournal84113781","article-title":"Absence of WAF1 mutations in a variety of human malignancies.","volume":"84","author":"Shiohara","year":"1994","journal-title":"Blood."},{"key":"2019111900180897300_B12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF02281873","article-title":"Characterization of the human p57KIP2 gene: alternative splicing, insertion\/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.","volume":"97","author":"Tokino","year":"1996","journal-title":"Hum Genet."},{"key":"2019111900180897300_B13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9440(10)64652-4","article-title":"p57KIP2 is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinting genes p57KIP2, IGF2, and H19.","volume":"157","author":"Hartmann","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111900180897300_B14","first-page":"1365","article-title":"Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.","volume":"12","author":"Kondo","year":"1996","journal-title":"Oncogene."},{"key":"2019111900180897300_B15","first-page":"4776","article-title":"Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.","volume":"46","author":"Theillet","year":"1986","journal-title":"Cancer Res."},{"key":"2019111900180897300_B16","first-page":"89","article-title":"Allelotype study of primary hepatocellular carcinoma.","volume":"51","author":"Fujimori","year":"1991","journal-title":"Cancer Res."},{"key":"2019111900180897300_B17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/318377a0","article-title":"Loss of genes on the short arm of chromosome 11 in bladder cancer.","volume":"318","author":"Fearon","year":"1985","journal-title":"Nature."},{"key":"2019111900180897300_B18","first-page":"711","article-title":"Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.","volume":"44","author":"Koufos","year":"1989","journal-title":"Am J Hum Genet."},{"key":"2019111900180897300_B19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0959-437X(05)80154-6","article-title":"Beckwith-Wiedemann syndrome, tumorigenesis and imprinting.","volume":"2","author":"Junien","year":"1992","journal-title":"Curr Opin Genet Dev."},{"key":"2019111900180897300_B20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1096-171","article-title":"An imprinted gene p57(KIP2) is mutated in Beckwith-Wiedemann syndrome.","volume":"14","author":"Hatada","year":"1996","journal-title":"Nat Genet."},{"key":"2019111900180897300_B21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/514854","article-title":"Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.","volume":"61","author":"O'Keefe","year":"1997","journal-title":"Am J Hum Genet."},{"key":"2019111900180897300_B22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng1095-204","article-title":"Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.","volume":"11","author":"Hatada","year":"1995","journal-title":"Nat Genet."},{"key":"2019111900180897300_B23","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1073\/pnas.93.7.3026","article-title":"Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.","volume":"93","author":"Matsuoka","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111900180897300_B24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/hmg\/5.8.1101","article-title":"Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.","volume":"5","author":"Chung","year":"1996","journal-title":"Hum Mol Genet."},{"key":"2019111900180897300_B25","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1182\/blood.V94.7.2445.419k19_2445_2451","article-title":"p15INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests diversity as a critical factor for transcriptional silencing.","volume":"94","author":"Cameron","year":"1999","journal-title":"Blood."},{"key":"2019111900180897300_B26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.leu.2401991","article-title":"Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia.","volume":"15","author":"Uchida","year":"2001","journal-title":"Leukemia."},{"key":"2019111900180897300_B27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/86934","article-title":"TSLC1 is a tumor-suppressor gene in human non-small cell lung cancer.","volume":"27","author":"Kuramochi","year":"2001","journal-title":"Nat Genet."},{"key":"2019111900180897300_B28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1349-7006.1991.tb01815.x","article-title":"Genetic alteration of p53 in some patients with adult T-cell leukemia.","volume":"82","author":"Nagai","year":"1991","journal-title":"Jpn J Cancer Res."},{"key":"2019111900180897300_B29","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1073\/pnas.86.8.2766","article-title":"Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.","volume":"86","author":"Orita","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111900180897300_B30","first-page":"880","article-title":"Allele-specific hypermethylation of retinoblastoma tumor-suppressor gene.","volume":"48","author":"Sakai","year":"1991","journal-title":"Am J Hum Genet."},{"key":"2019111900180897300_B31","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MST1 gene is frequently associated with aberrant DNA methylation in all common cancers.","volume":"55","author":"Herman","year":"1995","journal-title":"Cancer Res."},{"key":"2019111900180897300_B32","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16INK4A gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood."},{"key":"2019111900180897300_B33","first-page":"262","article-title":"Mechanism for inactivation of KIP family cyclin-dependent kinase inhibitor gene in gastric cancer cells.","volume":"60","author":"Shin","year":"2000","journal-title":"Cancer Res."},{"key":"2019111900180897300_B34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1054\/bjoc.2000.1298","article-title":"Decreased expression of p57KIP2 mRNA in human bladder cancer.","volume":"83","author":"Oya","year":"2000","journal-title":"Br J Cancer."},{"key":"2019111900180897300_B35","first-page":"771","article-title":"Expression of cell cycle regulatory genes in chronic myelogenous leukemia.","volume":"83","author":"Iolascon","year":"1998","journal-title":"Hematologica."},{"key":"2019111900180897300_B36","first-page":"56","article-title":"Genomic imprinting of human p57KIP2 and its reduced expression in Wilms tumors.","volume":"17","author":"Hatada","year":"1996","journal-title":"Hum Mol Genet."},{"key":"2019111900180897300_B37","first-page":"431","article-title":"Genomic imprinting: mechanism and role in human pathology.","volume":"144","author":"Tycko","year":"1994","journal-title":"Am J Pathol."},{"key":"2019111900180897300_B38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/8.7.1209","article-title":"LIT1, an imprinted antisense RNA in human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids.","volume":"8","author":"Mitsuya","year":"1999","journal-title":"Hum Mol Genet."},{"key":"2019111900180897300_B39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia."},{"key":"2019111900180897300_B40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/387151a0","article-title":"Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.","volume":"387","author":"Zhang","year":"1997","journal-title":"Nature."},{"key":"2019111900180897300_B41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/oxfordjournals.jbchem.a022586","article-title":"Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.","volume":"127","author":"Takahashi","year":"2000","journal-title":"J Biochem."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/7\/2572\/1255241\/h81902002572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/7\/2572\/1255241\/h81902002572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:18:25Z","timestamp":1574122705000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/7\/2572\/106234\/Aberrant-DNA-methylation-ofp57KIP2-gene-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-11-0026","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10,1]]}}}